Nifty Pharma
Dr Reddy's: Brokerage reports by JM Financial, Motilal Oswal as stock up 4%
DRL's management has guided for double-digit growth in FY26, with margins expected to remain similar to FY25 levels. Here's what brokerages expect from the company going ahead
 "Dr Reddy's: Brokerage reports by JM Financial, Motilal Oswal as stock up 4%")
Nifty Pharma drops 2% after Trump reveals plans to lower US drug cost
The US President has predicted that pharmaceutical prices could drop 30 per cent to 80 per cent in America
 "Nifty Pharma drops 2% after Trump reveals plans to lower US drug cost")
Dr Reddy's Q4 results preview: Analysts eye 18% jump in PAT; check details
Dr Reddy's Labs Q4 results 2025 date: Dr Reddy's Laboratories is scheduled to announce its fourth quarter (Q4FY25) results on Friday, May 9, 2025
 "Dr Reddy's Q4 results preview: Analysts eye 18% jump in PAT; check details")
These 3 pharma stocks have surged over 50% in April; check full list here
A total of 11 pharma and healthcare-related stocks have rallied more than 20% thus far in April on hopes of a likely softer tariff-related stance by the US President Donald Trump.
 "These 3 pharma stocks have surged over 50% in April; check full list here")
FIIs buy BFSI, telecom, metal stocks in March 2025; should you too?
Banking, financial services, and insurance (BFSI), telecom, and metals saw the highest FII flows in March 2025
 "FIIs buy BFSI, telecom, metal stocks in March 2025; should you too?")
Pharma stocks surge as Trump puts 90-day hold on planned tariffs
Nifty Pharma has fallen by 12.8 per cent so far this year, with Natco Pharma and Granules India leading the plunge
 "Pharma stocks surge as Trump puts 90-day hold on planned tariffs")
Biocon, Cipla: Nifty Pharma down 6% as US eyes possible tariffs on sector
Adding to the worries of investors, US is looking for possible tariffs on the pharmaceutical goods
 "Biocon, Cipla: Nifty Pharma down 6% as US eyes possible tariffs on sector")
Nifty Pharma jumps 5% as US exempts reciprocal tariff on pharma goods
All 20 Nifty Pharma constituents settled in the green. Among others, Ipca Laboratories was up 4.59 per cent, Lupin was up 4.19 per cent, Cipla was up 3.28 per cent, Sun Pharma was up 3.41 per cent
 "Nifty Pharma jumps 5% as US exempts reciprocal tariff on pharma goods")
Zydus Lifesciences, Granules, Glenmark: Nifty Pharma up despite weak market
Nifty Pharma among others has gained 0.8 per cent in trade, logging an intra-day high at 20,550.6
 "Zydus Lifesciences, Granules, Glenmark: Nifty Pharma up despite weak market")
Nifty Pharma tanks 3% on Trump's tariff threat; Zydus, Lupin down upto 10%
The decline in pharma stocks followed comments from President Donald Trump, who indicated that the US may impose tariffs of around 25 per cent on pharmaceutical, automobile, and semiconductor imports
 "Nifty Pharma tanks 3% on Trump's tariff threat; Zydus, Lupin down upto 10%")
How to trade Nifty Auto, IT, Pharma as Trump threatens up to 25% tariffs
Technical chart suggests that the Nifty Auto, IT and Pharma indices can potentially fall up to 22% from present levels if these key support levels are broken.
 "How to trade Nifty Auto, IT, Pharma as Trump threatens up to 25% tariffs")
Nifty Pharma index slips 3%; Natco, Glenmark, Lupin, Laurus down up to 10%
Thus far in the calendar year 2025, the Nifty Pharma index has slipped 11 per cent, as against 3.7 per cent fall in Nifty 50.
 "Nifty Pharma index slips 3%; Natco, Glenmark, Lupin, Laurus down up to 10%")
Alkem Labs, Ipca, Divi's: Three reasons why pharma stocks are falling today
Stocks such as Natco, Dr. Reddy's, Cipla, Mankind, Torrent, Sun Pharma, Abbott, and Glenmark slipped in the range of 1-2 per cent
 "Alkem Labs, Ipca, Divi's: Three reasons why pharma stocks are falling today")
Time to buy, sell, or hold stocks amid market sell-off? Analyst view here
IT, pharma, cement, and other sectors look attractive to analysts with no pre-budget rally in picture
 "Time to buy, sell, or hold stocks amid market sell-off? Analyst view here")
How to trade Nifty Pharma, Metal indices today, Jan 16? Check levels here
The Nifty Pharma Index is witnessing a bearish trend in the near term, with strong support anticipated in the range of 21,825 to 21,700
 "How to trade Nifty Pharma, Metal indices today, Jan 16? Check levels here")
Nomura's upgrade to 'Buy' lifts Dr Reddy's share over 4% in weak market
The northward move in Dr Reddy's share price came after Tokyo, Japan-based brokerage Nomura upgraded the stock to 'Buy' from 'Neutral'
 "Nomura's upgrade to 'Buy' lifts Dr Reddy's share over 4% in weak market")
How to trade Nifty Pharma, Energy indices today, Dec 11? Check levels here
Stock market today: What are the key support, resistance levels for the Nifty Pharma, and Energy indices? What should be the trading strategy? Here is your trading guide for stock market today
 "How to trade Nifty Pharma, Energy indices today, Dec 11? Check levels here")
Nifty Pharma jumps over 2%: Analysts decode the drivers behind the rally
Individually, Cipla soared up to 3.68 per cent to hit an intraday high of Rs 1,547.70 per share, while Sun Pharma soared up to 3.30 per cent to hit an intraday high of Rs 1,791.60 per share
 "Nifty Pharma jumps over 2%: Analysts decode the drivers behind the rally")
Ravi Nathani says Nifty FMCG still correcting, Pharma showing bearish trend
The Nifty FMCG index is currently exhibiting a downward trend in the near term, while Nifty Pharma index continues to exhibit a bearish trend in the near term
 "Ravi Nathani says Nifty FMCG still correcting, Pharma showing bearish trend")
Ravi Nathani suggests buying dips in Nifty Metal; sell on rise in pharma
Nifty Metal is currently approaching critical support levels between 8,800 and 8,700, while Nifty Pharma Index shows a clear downtrend on the charts
 "Ravi Nathani suggests buying dips in Nifty Metal; sell on rise in pharma")
